Literature DB >> 17270079

A theoretical and spectroscopic study of gamma-crystalline and amorphous indometacin.

Clare J Strachan1, Thomas Rades, Keith C Gordon.   

Abstract

Amorphous materials are prevalent in the pharmaceutical setting. Whether they are a help or hindrance, their physico-chemical characteristics must be investigated. However, the amorphous form remains a challenge to characterise with many of its properties poorly understood. In this study, gamma-crystalline and amorphous indometacin are investigated using vibrational spectroscopy and quantum chemical calculations. The structure of the single indometacin molecule and the dimer in the gamma-form were optimised using density functional theory calculations. The optimised structures were similar to the conformations in the crystal form, suggesting that conformation of the molecules in the crystal may be close to the average molecular structure in less-ordered states. Infrared and Raman spectra were calculated from the optimised structures. Many modes in the calculated spectra could be matched with the experimental spectra of the gamma-crystalline and amorphous forms, and a description of the matched modes has been provided. By analysis of the theoretical vibrational modes it was confirmed that the amorphous form of indometacin produced by quench cooling the melt consists predominantly of dimers, similar in structure to in the gamma-crystalline form. In addition, differences in intermolecular bonding between the two forms were identified. Quantum mechanical calculations allow improved understanding of amorphous materials and their vibrational spectra.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17270079     DOI: 10.1211/jpp.59.2.0012

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.

Authors:  E Kaminska; K Adrjanowicz; D Zakowiecki; B Milanowski; M Tarnacka; L Hawelek; M Dulski; J Pilch; W Smolka; I Kaczmarczyk-Sedlak; K Kaminski
Journal:  Pharm Res       Date:  2014-05-15       Impact factor: 4.200

2.  Low- versus Mid-frequency Raman Spectroscopy for in Situ Analysis of Crystallization in Slurries.

Authors:  Jaana Koskela; Joshua J Sutton; Tiina Lipiäinen; Keith C Gordon; Clare J Strachan; Sara J Fraser-Miller
Journal:  Mol Pharm       Date:  2022-05-03       Impact factor: 5.364

3.  Quantification of Process Induced Disorder in Milled Samples Using Different Analytical Techniques.

Authors:  Ulrike Zimper; Jaakko Aaltonen; Cushla M McGoverin; Keith C Gordon; Karen Krauel-Goellner; Thomas Rades
Journal:  Pharmaceutics       Date:  2010-02-16       Impact factor: 6.321

4.  Crystal structure of 4-[4-(eth-oxy-carbon-yl)piperazin-1-yl]benzoic acid.

Authors:  Md Serajul Haque Faizi; Musheer Ahmad; Irina A Golenya
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-08-09

5.  Poly[diammonium [(μ(4)-butane-1,2,3,4-tetra-carboxyl-ato)zincate] tetra-hydrate].

Authors:  Shouwen Jin; Yanfei Huang; Shuaishuai Wei; Yong Zhou; Yingping Zhou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-15

6.  3,3'-(Piperazine-1,4-diium-1,4-di-yl)di-propionate dihydrate.

Authors:  Shouwen Jin; Yanfei Huang; Hao Fang; Tianyi Wang; Liangliang Ding
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-01

7.  Fluorescence-suppressed time-resolved Raman spectroscopy of pharmaceuticals using complementary metal-oxide semiconductor (CMOS) single-photon avalanche diode (SPAD) detector.

Authors:  Tatu Rojalin; Lauri Kurki; Timo Laaksonen; Tapani Viitala; Juha Kostamovaara; Keith C Gordon; Leonardo Galvis; Sebastian Wachsmann-Hogiu; Clare J Strachan; Marjo Yliperttula
Journal:  Anal Bioanal Chem       Date:  2015-11-09       Impact factor: 4.142

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.